Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) Net Margin (2020 - 2025)

Celularity (CELU) has disclosed Net Margin for 6 consecutive years, with 594.23% as the latest value for Q4 2025.

  • For Q4 2025, Net Margin rose 133761.0% year-over-year to 594.23%; the TTM value through Dec 2025 reached 345.76%, down 18834.0%, while the annual FY2025 figure was 345.76%, 23899.0% down from the prior year.
  • Net Margin hit 594.23% in Q4 2025 for Celularity, down from 436.66% in the prior quarter.
  • Across five years, Net Margin topped out at 1266.58% in Q2 2022 and bottomed at 3063.73% in Q1 2021.
  • Average Net Margin over 5 years is 668.99%, with a median of 300.5% recorded in 2025.
  • Year-over-year, Net Margin soared 328474bps in 2022 and then crashed -289861bps in 2023.
  • Celularity's Net Margin stood at 83.2% in 2021, then soared by 811bps to 591.77% in 2022, then tumbled by -87bps to 78.82% in 2023, then plummeted by -2551bps to 1931.83% in 2024, then surged by 69bps to 594.23% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 594.23%, 436.66%, and 427.6% for Q4 2025, Q3 2025, and Q2 2025 respectively.